Loxo Oncology Announces Submission of European Marketing Authorization Application for Larotrectinib

World News: . []

STAMFORD Conn Aug 27 2018 GLOBE NEWSWIRE -- Loxo LINK  Inc NasdaqLOXO a biopharmaceutical company developing highly LINK  medicines for patients with genomically LINK  cancers today announced that its collaboration LINK  Bayer, ...

More news and information about Loxo Oncology, Inc.

Published By:

Globe Newswire: 07:30 GMT Monday 27th August 2018

Published: .

Search for other references to "loxo" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us